David Pendarvis - Jun 3, 2021 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Administrative Officer
Signature
David Pendarvis, Chief Administrative Officer
Stock symbol
RMD
Transactions as of
Jun 3, 2021
Transactions value $
-$307,809
Form type
4
Date filed
6/7/2021, 01:10 PM
Next filing
Jul 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale -$308K -1.49K -1.16% $207.00 126K Jun 3, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.
F2 Includes 66.72 shares of ResMed stock purchased on April 30, 2021, through the ResMed Employee Stock Purchase Plan.